Vivopod O

Broad-Spectrum Protection for Faster Recovery

10x10 Tablets

Pharma

Antibacterial

Product highlights

Dual-action antibiotic combination.
Effective against Gram-positive and Gram-negative bacteria.
Broad-spectrum coverage in mixed infections.
Helps achieve rapid symptomatic relief and recovery.
Suitable for respiratory, urinary and gastrointestinal infections.

VIVOPOD-O is a broad-spectrum antibacterial combination containing Cefpodoxime Proxetil and Ofloxacin. It provides synergistic action against susceptible microorganisms and is useful in respiratory tract infections, urinary tract infections, gastrointestinal infections, skin and soft tissue infections and other mixed bacterial infections.

Dosage Form

Film-coated Tablets

Product Name

VIVOPOD-O

Composition

Each tablet contains Cefpodoxime Proxetil equivalent to Cefpodoxime 200 mg and Ofloxacin 200 mg.

Therapeutic Segment

Anti-infective / Antibiotic

Pharmacological Action

Broad-spectrum antibacterial with enhanced tissue penetration and β-lactamase protection

Mechanism

Cefpodoxime inhibits bacterial cell wall synthesis whereas Ofloxacin inhibits DNA gyrase and topoisomerase IV, resulting in bacterial cell death.

Key Clinical Benefits

Broad-spectrum coverage, rapid symptom control, improved bacterial eradication and better clinical outcomes.

Key Indications

Respiratory tract infections, urinary tract infections, gastrointestinal infections, skin and soft tissue infections and ENT infections.

Administration

For oral use. Preferably taken after meals and as directed by the physician.

Recommended Usage

As directed by the physician depending upon severity and type of infection.

Dosage Form

Film-coated Tablets

Product Name

VIVOPOD-O

Composition

Each tablet contains Cefpodoxime Proxetil equivalent to Cefpodoxime 200 mg and Ofloxacin 200 mg.

Therapeutic Segment

Anti-infective / Antibiotic

Pharmacological Action

Anti-infective / Antibiotic

Mechanism

Cefpodoxime inhibits bacterial cell wall synthesis whereas Ofloxacin inhibits DNA gyrase and topoisomerase IV, resulting in bacterial cell death.

Key Clinical Benefits

Broad-spectrum coverage, rapid symptom control, improved bacterial eradication and better clinical outcomes.

Key Indications

Respiratory tract infections, urinary tract infections, gastrointestinal infections, skin and soft tissue infections and ENT infections.

Administration

For oral use. Preferably taken after meals and as directed by the physician.

Recommended Usage

As directed by the physician depending upon severity and type of infection.

Explore Similar Products

Fast, Powerful Acid Suppression with Quick Symptom Control

Fast Relief from Pain, Swelling & Inflammation

10x10 Protected Relief Capsules

Pharma

Pain Relief

RABNEXT-A

Treat Pain. Protect the Stomach.

Healthy Blood, Healthy Pregnancy

Trusted progesterone for better reproductive care.

Triple Neuro Support for Faster Nerve Repair

Therapeutic Segments

0 +

Years of Operations

0 +

Key Brands

0 +

Quality Assurance

0 %

Vivopod O

Product highlights

Explore Similar Products

Request a Free Quote